Search results
Results from the WOW.Com Content Network
Acral erythema is a common adverse reaction to cytotoxic chemotherapy drugs, particularly cabozantinib, cytarabine, doxorubicin, and fluorouracil and its prodrug capecitabine. [3] Targeted cancer therapies, especially the tyrosine kinase inhibitors sorafenib and sunitinib, have also been associated with a high incidence of acral erythema ...
Chemotherapy-induced acral erythema (palmoplantar erythrodysesthesia syndrome) Chemotherapy-induced hyperpigmentation; Drug-induced acne; Drug-induced angioedema; Drug-related gingival hyperplasia; Drug-induced lichenoid reaction (drug-induced lichen planus, lichenoid drug eruption) Drug-induced lupus erythematosus; Drug-induced nail changes
Chemotherapy-induced acral erythema; Chemotherapy-induced hyperpigmentation; D. Dilantin hypersensitivity syndrome; Drug rash with eosinophilia and systemic symptoms;
Chemotherapy-induced hyperpigmentation is caused by many chemotherapeutic agents (especially the antibiotics bleomycin, and daunorubicin) and the alkylating agents (cyclophosphamide and busulfan). [ 1 ] : 132
Chemotherapy-induced acral erythema; D. Deep gyrate erythema; E. Erythema annulare centrifugum; Erythema chronicum migrans; Erythema gyratum repens; Erythema marginatum;
E800 Railway accident involving collision with rolling stock; E801 Railway accident involving collision with other object; Excludes: Collision with: aircraft (E840-E842) or motor vehicle (E810.-, E820-E822)
This oncologist agreed to treat me and I started chemotherapy immediately. Altogether, I had treatment for seven months: six rounds of intense chemo and 25 rounds of radiation. Because I had such ...
This page was last edited on 19 January 2024, at 04:21 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.